A Cautious Industry View of the Promise of Senolytics

Source https://www.fightaging.org/archives/2022/12/a-cautious-industry-view-of-the-promise-of-senolytics/

This article on senolytic therapies to selectively remove senescent cells in old tissues is in part a matter of Unity Biotechnology talking up their position. The company suffered from first mover disadvantage in bringing senolytic drugs into clinical development. The field has made progress very rapidly over the last decade, and startups founded even just a couple of years after Unity’s launch benefited from greater knowledge and a selection of better technologies to work with. Still, one can be talking up one’s position and also be right. The accumulation of senescent cells is profoundly harmful, a significant contribution to degenerative aging, and senolytics are indeed a promising approach to…

Source https://www.fightaging.org/archives/2022/12/a-cautious-industry-view-of-the-promise-of-senolytics/

This article on senolytic therapies to selectively remove senescent cells in old tissues is in part a matter of Unity Biotechnology talking up their position. The company suffered from first mover disadvantage in bringing senolytic drugs into clinical development. The field has made progress very rapidly over the last decade, and startups founded even just a couple of years after Unity’s launch benefited from greater knowledge and a selection of better technologies to work with. Still, one can be talking up one’s position and also be right. The accumulation of senescent cells is profoundly harmful, a significant contribution to degenerative aging, and senolytics are indeed a promising approach to…

What Do You Think?

comments

Translate »